AGM

The fact that they have been directly approached by 6 multinational medical device companies suggests that it is very likely that a partnership / licensing deal will be in play during 2016 on completion of the clinical trials.

Also the number of new indications is very positive and highlights the potential of the product to become an essential part of a women's life and incorporated in their everyday routine.